AI Echocardiography Software Market
完整報告名稱與涵蓋範圍
AI Echocardiography Software Market Size, Share & Trends Analysis Report, By Software Function (Automated Measurement and Quantification, Image Acquisition Guidance for Novice Users, Disease Detection and Diagnostic Support, Workflow, Reporting and Cloud Analytics), By Deployment (Cloud-Based, Embedded in Ultrasound Systems, On-Premise), By Application (Heart Failure and Ejection Fraction Assessment, Valvular Heart Disease, Cardiomyopathy and Structural Screening, Point-of-Care and Emergency Cardiac Assessment), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The AI echocardiography software market covers algorithms and platforms that automate measurement and quantification of cardiac ultrasound images, guide image acquisition for non-expert users, detect disease and support diagnosis and streamline reporting and analytics, delivered as cloud services, embedded ultrasound features or on-premise systems. Ultrasound hardware is excluded except where AI software is licensed separately; the point-of-care ultrasound device market is addressed in an existing InsightAce study.
Echocardiography is the most common cardiac imaging test yet remains operator-dependent and labour-intensive, and AI is addressing both constraints: automated chamber quantification, strain analysis and valve assessment cut reading time and variability, while acquisition guidance allows nurses and primary care clinicians to obtain diagnostic-quality images. Regulatory clearances now span automated measurement, guidance and disease detection, and health systems deploy the software to expand heart failure and valve disease screening, manage sonographer shortages and standardise reporting. Vendors compete on validation breadth, integration with ultrasound consoles and picture archiving systems, reimbursement strategy and the ability to serve point-of-care and remote settings.
North America and Europe lead adoption, with Asia Pacific growing through embedded AI on domestic ultrasound platforms in China, Japan and South Korea. Competition involves AI cardiology software specialists, ultrasound system manufacturers with embedded AI and point-of-care device companies.
The InsightAce study supplies US$ forecasts for all software function, deployment, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI Echocardiography Software Market Snapshot
Chapter 4. Global AI Echocardiography Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Software Function Estimates & Trend Analysis
5.1. Software Function & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Software Function:
5.2.1. Automated Measurement and Quantification
5.2.2. Image Acquisition Guidance for Novice Users
5.2.3. Disease Detection and Diagnostic Support
5.2.4. Workflow, Reporting and Cloud Analytics
Chapter 6. Market Segmentation 2: By Deployment Estimates & Trend Analysis
6.1. Deployment & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment:
6.2.1. Cloud-Based
6.2.2. Embedded in Ultrasound Systems
6.2.3. On-Premise
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Heart Failure and Ejection Fraction Assessment
7.2.2. Valvular Heart Disease
7.2.3. Cardiomyopathy and Structural Screening
7.2.4. Point-of-Care and Emergency Cardiac Assessment
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Echocardiography Laboratories
8.2.2. Cardiology and Primary Care Clinics
8.2.3. Point-of-Care and Emergency Settings
Chapter 9. AI Echocardiography Software Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Us2.ai Pte Ltd.
11.2. Ultromics Ltd.
11.3. GE HealthCare Technologies Inc. (Caption Health)
11.4. Philips
11.5. Siemens Healthineers AG
11.6. EchoNous, Inc.
11.7. DiA Imaging Analysis (Philips)
11.8. AISAP Ltd.
11.9. Canon Medical Systems Corporation
11.10. Mindray Medical International Limited
11.11. Butterfly Network, Inc.
11.12. Exo Imaging, Inc.
11.13. Fujifilm Sonosite, Inc.
11.14. Samsung Medison Co., Ltd.
11.15. TOMTEC Imaging Systems (Philips)
圖表清單 List of Tables & Figures
Table 1. Global AI Echocardiography Software Revenue Forecast by Software Function, 2026-2035 (US$ Mn)
Figure 1. Global AI Echocardiography Software Market Snapshot, 2026 & 2035
Table 2. Global AI Echocardiography Software Revenue Forecast by Deployment, 2026-2035 (US$ Mn)
Figure 2. Global AI Echocardiography Software Market Share by Deployment, 2026 & 2035
Table 3. Global AI Echocardiography Software Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. AI Echocardiography Functions Across Acquisition, Measurement, Diagnosis and Reporting
Table 4. Global AI Echocardiography Software Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Sonographer Workforce Gap and AI-Enabled Throughput Improvements by Region
Table 5. North America AI Echocardiography Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific AI Echocardiography Software Growth Opportunity Analysis
Table 6. Europe AI Echocardiography Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Embedded Versus Cloud AI Delivery Models Among Ultrasound Manufacturers and Software Vendors
Table 7. Asia Pacific AI Echocardiography Software Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key AI Echocardiography Software Market Participants
Table 8. Latin America and Middle East & Africa AI Echocardiography Software Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們